Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
3.64M
-
Shares change
-
+1.21M
-
Total reported value, excl. options
-
$26.1M
-
Value change
-
+$8.72M
-
Put/Call ratio
-
0
-
Number of buys
-
33
-
Number of sells
-
-6
-
Price
-
$7.19
Significant Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) as of Q2 2023
50 filings reported holding PLSE - PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share as of Q2 2023.
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.64M shares
of 69.1M outstanding shares and own 5.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (922K shares), BANK OF AMERICA CORP /DE/ (783K shares), GEODE CAPITAL MANAGEMENT, LLC (309K shares), VANGUARD GROUP INC (290K shares), STATE STREET CORP (285K shares), GRIFFIN ASSET MANAGEMENT, INC. (194K shares), NORTHERN TRUST CORP (177K shares), Westside Investment Management, Inc. (70.1K shares), Spotlight Asset Group, Inc. (66.4K shares), and OSAIC HOLDINGS, INC. (59K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.